By Dr Michael Hancock, Endocrinologist, and Anneika Curtois, Diabetes Educator
Investigating and managing both type 1 diabetes (T1D) and type 2 diabetes (T2D) is rapidly evolving with the increasing uptake of advanced diabetes technologies.
Continuous glucose monitoring (CGM) and insulin pump therapy, particularly hybrid closed-loop (HCL) systems, are now central to best-practice care in T1D, while CGM technology is playing a growing role in T2D management.
For many GPs, these technologies may feel unfamiliar and outside of traditional care models, and their rapid evolution and integration into care may be overwhelming....
Investigating and managing both type 1 diabetes (T1D) and type 2 diabetes (T2D) is rapidly evolving with the increasing uptake of advanced diabetes technologies.
Continuous glucose monitoring (CGM) and insulin pump therapy, particularly hybrid closed-loop (HCL) systems, are now central to best-practice care in T1D, while CGM technology is playing a growing role in T2D management.
For many GPs, these technologies may feel unfamiliar and outside of traditional care models, and their rapid evolution and integration into care may be overwhelming....
This content is restricted to Medical Forum readers; this is a new feature. If you haven’t registered with our site in the last few weeks, please create a new account below. If you have subscribed, please log in.